- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2859
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cell culture efforts to reduce glycation in recombinant humanized antibody ; volume:5 ; number:1 ; day:10 ; month:10 ; year:2006 ; pages:1-2 ; date:10.2006
Microbial cell factories ; 5, Heft 1 (10.10.2006), 1-2, 10.2006
- Urheber
-
Yuk, Inn H.
- Beteiligte Personen und Organisationen
-
Huynh, Hung
Leach, Kimberly
Shen, Amy
Zhang, Boyan
Dutina, George
McKay, Patrick
Lim, Amy
Snedecor, Brad
SpringerLink (Online service)
- DOI
-
10.1186/1475-2859-5-S1-P57
- URN
-
urn:nbn:de:1111-2016072545454
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yuk, Inn H.
- Huynh, Hung
- Leach, Kimberly
- Shen, Amy
- Zhang, Boyan
- Dutina, George
- McKay, Patrick
- Lim, Amy
- Snedecor, Brad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances in recombinant antibody manufacturing
A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies
A recombinant antibody toolbox for Dictyostelium discoideum
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors
Humanized mice
Humanized mice
A humanized neutralizing antibody protects against human adenovirus type 7 infection in humanized desmoglein-2 and CD46 double-receptor transgenic mice
Phase I first-in-human study of HLX07, a novel and improved recombinant anti-EGFR humanized monoclonal antibody, in patients with advanced solid cancers
Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses
Development of an EGFRvIII specific recombinant antibody
Advances in recombinant antibody manufacturing
A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies
A recombinant antibody toolbox for Dictyostelium discoideum
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors
Humanized mice
Humanized mice
A humanized neutralizing antibody protects against human adenovirus type 7 infection in humanized desmoglein-2 and CD46 double-receptor transgenic mice
Phase I first-in-human study of HLX07, a novel and improved recombinant anti-EGFR humanized monoclonal antibody, in patients with advanced solid cancers
Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses
Development of an EGFRvIII specific recombinant antibody
Advances in recombinant antibody manufacturing
A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies
A recombinant antibody toolbox for Dictyostelium discoideum
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors
Humanized mice
Humanized mice
A humanized neutralizing antibody protects against human adenovirus type 7 infection in humanized desmoglein-2 and CD46 double-receptor transgenic mice
Phase I first-in-human study of HLX07, a novel and improved recombinant anti-EGFR humanized monoclonal antibody, in patients with advanced solid cancers
Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses